The effect of the sodium-glucose cotransporter type-2 inhibitor dapagliflozin on glomerular filtration rate in healthy cats
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Animal Science and Zoology,Food Animals
Reference26 articles.
1. A novel approach to control hyperglycemia in type 2 diabetes: sodium glucose co-transport (sglt) inhibitors. Systematic review and meta-analysis of randomized trials;Musso;Ann Med,2012
2. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (depict-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial;Dandona;Lancet Diabetes Endocrinol,2017
3. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the depict-1 52-week study;Dandona;Diabetes Care,2018
4. Regulatory mechanisms of na(+)/glucose cotransporters in renal proximal tubule cells;Lee;Kidney Int Suppl,2007
5. Sodium-glucose cotransporter-2 inhibition and the glomerulus: a review;Kalra;Adv Ther,2016
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?;Journal of Veterinary Pharmacology and Therapeutics;2024-07-13
2. The Future of Diabetes Therapies;Veterinary Clinics of North America: Small Animal Practice;2023-05
3. Sodium–glucose cotransporter 2 inhibition does not improve the acute pressure natriuresis response in rats with type 1 diabetes;Experimental Physiology;2023-01-15
4. Acute kidney injury manifesting as renal tubular acidosis with proximal and distal renal tubular dysfunction in a dog with acute pancreatitis;Journal of Veterinary Emergency and Critical Care;2022-02-07
5. Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy;World Journal of Cardiology;2021-12-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3